Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, Schlumberger M, Shah M, Waguespack SG; American Thyroid Association Guidelines Task Force on Medullary Thyroid Carcinoma.
Thyroid. 2015 Jun;25(6):567-610. doi: 10.1089/thy.2014.0335.
Familial non-medullary thyroid carcinoma: an update.
Nosé V.
Endocr Pathol. 2008 Winter;19(4):226-40. doi: 10.1007/s12022-008-9045-z.
Medullary thyroid carcinoma.
Griebeler ML, Gharib H, Thompson GB.
Endocr Pract. 2013 Jul-Aug;19(4):703-11. doi: 10.4158/EP12430.RA.
Genomics and Epigenomics of Medullary Thyroid Carcinoma: From Sporadic Disease to Familial Manifestations.
Barletta JA, Nosé V, Sadow PM.
Endocr Pathol. 2021 Mar;32(1):35-43. doi: 10.1007/s12022-021-09664-3. Epub 2021 Jan 25.
Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys.
Sánchez-Ares M, Cameselle-García S, Abdulkader-Nallib I, Rodríguez-Carnero G, Beiras-Sarasquete C, Puñal-Rodríguez JA, Cameselle-Teijeiro JM.
Front Endocrinol (Lausanne). 2022 Feb 28;13:829103. doi: 10.3389/fendo.2022.829103. eCollection 2022.
[Familial medullary thyroid carcinoma: case report and literature review.].
Barletta Carrillo CF, Poterico Rojas JA, Barrionuevo Cornejo C, Casavilca Zambrano S, Pinedo Cárdenas A, Quispe Santibañez I, Castro Mujica MDC.
Rev Fac Cien Med Univ Nac Cordoba. 2018 Dec 12;75(4):303-309. doi: 10.31053/1853.0605.v75.n4.20947.
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine.
Matrone A, Gambale C, Prete A, Elisei R.
Front Endocrinol (Lausanne). 2022 Mar 29;13:864253. doi: 10.3389/fendo.2022.864253. eCollection 2022.
Metastatic medullary thyroid carcinoma (MTC): disease course, treatment modalities and factors predisposing for drug resistance.
Saltiki K, Simeakis G, Karapanou O, Paschou SA, Alevizaki M.
Endocrine. 2023 Jun;80(3):570-579. doi: 10.1007/s12020-022-03296-1. Epub 2023 Jan 10.
Histopathology of C Cells and Medullary Thyroid Carcinoma.
Cameselle-Teijeiro JM, Sobrinho-Simões M.
Recent Results Cancer Res. 2025;223:9-50. doi: 10.1007/978-3-031-80396-3_2.
New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
Jaggard MK, MacRae C, Ifeacho S, Robinson S, Tolley NS.
J Laryngol Otol. 2009 Jul;123(7):796-800. doi: 10.1017/S0022215108003472. Epub 2008 Sep 4.
